These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21868610)

  • 1. Successful treatment of long-term, poststroke, upper-limb spasticity with onabotulinumtoxinA.
    Patel AT
    Phys Ther; 2011 Nov; 91(11):1636-41. PubMed ID: 21868610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
    Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative measurement of poststroke spasticity and response to treatment with botulinum toxin: a 2-patient case report.
    Cousins E; Ward AB; Roffe C; Rimington LD; Pandyan AD
    Phys Ther; 2009 Jul; 89(7):688-97. PubMed ID: 19482901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy and safety of incobotulinumtoxinA and conventional treatment of poststroke arm spasticity: a prospective, non-interventional, open-label, parallel-group study.
    Dressler D; Rychlik R; Kreimendahl F; Schnur N; Lambert-Baumann J
    BMJ Open; 2015 Dec; 5(12):e009358. PubMed ID: 26719317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity.
    Kanovský P; Slawek J; Denes Z; Platz T; Sassin I; Comes G; Grafe S
    Clin Neuropharmacol; 2009; 32(5):259-65. PubMed ID: 19644361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
    Jost WH; Hefter H; Reissig A; Kollewe K; Wissel J
    J Neurol Sci; 2014 Feb; 337(1-2):86-90. PubMed ID: 24361062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.
    Yablon SA; Brin MF; VanDenburgh AM; Zhou J; Garabedian-Ruffalo SM; Abu-Shakra S; Beddingfield FC
    Mov Disord; 2011 Feb; 26(2):209-15. PubMed ID: 20960474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.
    Senkárová Z; Hlustík P; Otruba P; Herzig R; Kanovský P
    J Neuroimaging; 2010 Jan; 20(1):9-15. PubMed ID: 19453837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contralateral weakness following botulinum toxin for poststroke spasticity.
    Thomas AM; Simpson DM
    Muscle Nerve; 2012 Sep; 46(3):443-8. PubMed ID: 22907238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constraint-Induced Movement Therapy After Injection of Botulinum Toxin Type A for a Patient With Chronic Stroke: One-Year Follow-up Case Report.
    Amano S; Takebayashi T; Hanada K; Umeji A; Marumoto K; Furukawa K; Domen K
    Phys Ther; 2015 Jul; 95(7):1039-45. PubMed ID: 25592185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients.
    Albani G; Cimolin V; Galli M; Vimercati S; Bar D; Campanelli L; Gandolfi R; Lombardi R; Mauro A
    Funct Neurol; 2010; 25(2):103-7. PubMed ID: 20923608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
    Yablon SA; Brashear A; Gordon MF; Elovic EP; Turkel CC; Daggett S; Liu J; Brin MF
    Clin Ther; 2007 Apr; 29(4):683-90. PubMed ID: 17617291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measuring outcome in spasticity rehabilitation].
    Fheodoroff K; Wissel J; Entner T; Freimüller M
    Wien Klin Wochenschr; 2001; 113 Suppl 4():11-5. PubMed ID: 15506046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke.
    Veverka T; Hluštík P; Tomášová Z; Hok P; Otruba P; Král M; Tüdös Z; Zapletalová J; Herzig R; Krobot A; Kaňovský P
    J Neurol Sci; 2012 Aug; 319(1-2):89-95. PubMed ID: 22687958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S; Turner-Stokes L
    Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OnabotulinumtoxinA for the Treatment of Poststroke Distal Lower Limb Spasticity: A Randomized Trial.
    Wein T; Esquenazi A; Jost WH; Ward AB; Pan G; Dimitrova R
    PM R; 2018 Jul; 10(7):693-703. PubMed ID: 29330071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
    Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
    Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal Muscle Selection for OnabotulinumtoxinA Injections in Poststroke Lower-Limb Spasticity: A Randomized Trial.
    Esquenazi A; Wein TH; Ward AB; Geis C; Liu C; Dimitrova R
    Am J Phys Med Rehabil; 2019 May; 98(5):360-368. PubMed ID: 31003229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.